BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769
8 results:

  • 1. The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.
    Tzelnick S; Soroka HP; Tasnim N; Gilbert RW; Irish JC; Goldstein DP; Brown D; Gullane P; Chepeha DB; Yao CMKL; Sahovaler A; Witterick IJ; Monteiro E; Davies J; Huang SH; O'Sullivan B; Hahn E; Hosni A; Razak AA; Gupta AA; de Almeida JR
    Oral Oncol; 2023 Oct; 145():106495. PubMed ID: 37478572
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
    Martin-Giacalone BA; Richard MA; Scheurer ME; Khan J; Sok P; Shetty PB; Chanock SJ; Li SA; Yeager M; Marquez-Do DA; Barkauskas DA; Hall D; McEvoy MT; Brown AL; Sabo A; Scheet P; Huff CD; Skapek SX; Hawkins DS; Venkatramani R; Mirabello L; Lupo PJ
    J Natl Cancer Inst; 2023 Jun; 115(6):733-741. PubMed ID: 36951526
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
    Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
    Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
    Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of germline gata2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
    Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
    Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma.
    Jakob J; Hohenberger P
    Cancer; 2016 Sep; 122(17):2624-32. PubMed ID: 27197621
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Zer A; Ding K; Lee SM; Goss GD; Seymour L; Ellis PM; Hackshaw A; Bradbury PA; Han L; O'Callaghan CJ; Tsao MS; Shepherd FA
    J Thorac Oncol; 2016 Mar; 11(3):312-23. PubMed ID: 26749487
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos.
    Brown LA; Rodaway AR; Schilling TF; Jowett T; Ingham PW; Patient RK; Sharrocks AD
    Mech Dev; 2000 Feb; 90(2):237-52. PubMed ID: 10640707
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.